olivLaw · US equity research
Corteva, Inc. CTVA
Agricultural Production-Crops · SIC 0100 · Vertical: Agricultural Production-Crops (SIC 0100)
Corteva is a global provider of seed and crop protection solutions, headquartered in Indianapolis, aiming to give farmers more productive and sustainable products. The company is nearing a planned separation of its two businesses targeted for October 1, 2026, which keeps its structure and outlook in focus. Net sales reached 17.4 billion USD in 2025, and 11.28 billion USD in the first half of 2026.
At the close of 04 Nov 2026, Corteva, Inc. (CTVA) stock was 12.26 USD (+3.20% on the day), with market capitalisation 8.2 bn USD, P/E 8.1 on diluted EPS of 1.51 USD over the last 12 months, dividend yield 5.87%, beta 0.47, 52-week range 9.48–14.45 USD. Latest reported quarter (Q2 2026): revenue of 6.4 bn USD (−1.2% YoY), net income of 1.2 bn USD (−11.6% YoY), diluted EPS 1.73 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 49.1
- neutral
- Bollinger (20, 2)
- 11.11 – 13.93
- in the lower half of the band · %B 0.41 · band width 22.5%
- SMA 50 / 200
- 12.52 / 12.11
- mixed trend
- MACD (12, 26, 9)
- -0.22 / -0.15
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −1.0% | −1.1% | +0.0 pp | — |
| 3 months | +3.9% | −0.5% | +4.3 pp | — |
| 6 months | −0.1% | +4.4% | −4.5 pp | — |
| Year to date | +21.9% | +12.3% | +9.6 pp | — |
| 1 year | +30.7% | +13.5% | +17.2 pp | −26.0% |
| 3 years | +62.7% | +76.4% | −13.7 pp | −31.5% |
| 5 years | +71.7% | +63.7% | +8.0 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.3 bn | 4.0 bn | 4.4 bn | 6.5 bn | 2.6 bn | 3.9 bn | 4.9 bn | 6.4 bn |
| Cost of revenue | 1.6 bn | 2.5 bn | 2.3 bn | 2.9 bn | 1.6 bn | 2.3 bn | 2.4 bn | 2.7 bn |
| Research & development | 348.0 m | 365.0 m | 335.0 m | 375.0 m | 351.0 m | 413.0 m | 341.0 m | 388.0 m |
| SG&A | 671.0 m | 735.0 m | 751.0 m | 1.2 bn | 725.0 m | 860.0 m | 877.0 m | 1.2 bn |
| Depreciation & amortisation | 306.0 m ≈ | 302.0 m | 296.0 m | 301.0 m | 300.0 m ≈ | 306.0 m | 297.0 m | 339.0 m ≈ |
| Interest expense | 66.0 m | 60.0 m | 36.0 m | 52.0 m | 46.0 m ≈ | 46.0 m | 36.0 m | 47.0 m |
| Pre-tax income | -633.0 m | 88.0 m | 784.0 m | 1.8 bn | -370.0 m | -530.0 m | 858.0 m | 1.6 bn |
| Income tax | -114.0 m | 138.0 m | 117.0 m | 422.0 m | -62.0 m | 7.0 m | 133.0 m | 408.0 m |
| Net income | -524.0 m | -41.0 m | 652.0 m | 1.3 bn | -320.0 m | -552.0 m | 720.0 m | 1.2 bn |
| Diluted EPS | -0.76 | -0.06 ≈ | 0.95 | 1.92 | -0.47 | -0.82 ≈ | 1.07 | 1.73 |
| Operating cash flow | 130.0 m ≈ | 4.2 bn | -2.1 bn | 947.0 m ≈ | 193.0 m ≈ | 4.4 bn | -2.9 bn | -466.0 m ≈ |
| Capex | 154.0 m ≈ | 181.0 m | 94.0 m | 118.0 m ≈ | 157.0 m ≈ | 222.0 m | 81.0 m | 122.0 m ≈ |
| Dividends paid | 117.0 m ≈ | 118.0 m | 116.0 m | 116.0 m ≈ | 122.0 m ≈ | 121.0 m | 121.0 m | 120.0 m ≈ |
| Share repurchases | 253.0 m ≈ | 252.0 m | 270.0 m | 250.0 m ≈ | 250.0 m ≈ | 301.0 m | 250.0 m | 250.0 m ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 88 percentile of its own 25-quarter history (min 2.9, median 5.8, max 10.9; quarters with earnings only).
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.3 bn | 13.8 bn | 14.2 bn | 15.7 bn | 17.5 bn | 17.2 bn | 16.9 bn | 17.4 bn |
| Revenue YoY | unavailable | −3.1% | +2.7% | +10.1% | +11.5% | −1.3% | −1.8% | +2.9% |
| Net income | -5.1 bn | -959.0 m | 681.0 m | 1.8 bn | 1.1 bn | 735.0 m | 907.0 m | 1.1 bn |
| Net income YoY | unavailable | unavailable | unavailable | +158.3% | −34.8% | −35.9% | +23.4% | +20.6% |
| Diluted EPS | -6.76 | -1.28 | 0.91 | 2.37 | 1.58 | 1.03 | 1.30 | 1.60 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | +160.4% | −33.3% | −34.8% | +26.2% | +23.1% |
| net % | -35.5% | -6.9% | 4.8% | 11.2% | 6.6% | 4.3% | 5.4% | 6.3% |
| Free cash flow | -1.0 bn | -93.0 m | 1.6 bn | 2.2 bn | 267.0 m | 1.2 bn | 1.5 bn | 2.8 bn |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 4.5 bn USD
- Financial debt
- 894.0 m USD
- Net debt
- -3.6 bn USD
- Equity
- 24.4 bn USD
- Total assets
- 42.8 bn USD
- Debt / equity
- 0.04x
- Current ratio
- 1.43x
- ROE
- 4.5%
- ROA
- 2.6%
- FCF margin
- 16.2%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 14.2 bn | 15.7 bn | 17.5 bn | 17.2 bn | 16.9 bn | 17.4 bn | SEC (XBRL)· 12 Feb 2026verified |
| Cost of revenue | 8.5 bn | 9.2 bn | 10.4 bn | 9.9 bn | 9.5 bn | 9.2 bn | SEC (XBRL)· 12 Feb 2026verified |
| Gross profit | 5.7 bn ≈ | 6.4 bn ≈ | 7.0 bn ≈ | 7.3 bn ≈ | 7.4 bn ≈ | 8.2 bn ≈ | SEC (XBRL)· 12 Feb 2026derived |
| Research & development | 1.1 bn | 1.2 bn | 1.2 bn | 1.3 bn | 1.4 bn | 1.5 bn | SEC (XBRL)· 12 Feb 2026verified |
| SG&A | 3.0 bn | 3.2 bn | 3.2 bn | 3.2 bn | 3.2 bn | 3.5 bn | SEC (XBRL)· 12 Feb 2026verified |
| Depreciation & amortisation | 1.2 bn | 1.2 bn | 1.2 bn | 1.2 bn | 1.2 bn | 1.2 bn | SEC (XBRL)· 12 Feb 2026verified |
| Interest expense | 45.0 m | 30.0 m | 79.0 m | 233.0 m | 233.0 m | 180.0 m | SEC (XBRL)· 12 Feb 2026verified |
| Pre-tax income | 675.0 m | 2.3 bn | 1.4 bn | 1.1 bn | 1.3 bn | 1.7 bn | SEC (XBRL)· 12 Feb 2026verified |
| Income tax | -81.0 m | 524.0 m | 210.0 m | 152.0 m | 412.0 m | 484.0 m | SEC (XBRL)· 12 Feb 2026verified |
| Net income | 681.0 m | 1.8 bn | 1.1 bn | 735.0 m | 907.0 m | 1.1 bn | SEC (XBRL)· 12 Feb 2026verified |
| Diluted EPS | 0.91 | 2.37 | 1.58 | 1.03 | 1.30 | 1.60 | SEC (XBRL)· 12 Feb 2026verified |
| Weighted average diluted shares | 751.2 m | 741.6 m | 724.5 m | 711.9 m | 696.0 m | 681.4 m | SEC (XBRL)· 12 Feb 2026verified |
| Dividend per share | 0.52 | 0.52 | 0.58 | 0.62 | 0.66 | 0.70 | SEC (XBRL)· 12 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Revenue − Cost of revenue.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 3.5 bn | 4.5 bn | 3.2 bn | 2.6 bn | 3.1 bn | 4.5 bn | SEC (XBRL)· 12 Feb 2026verified |
| Receivables | 3.8 bn | 3.4 bn | 4.2 bn | 4.2 bn | 4.4 bn | 4.9 bn | SEC (XBRL)· 12 Feb 2026verified |
| Inventories | 4.9 bn | 5.2 bn | 6.8 bn | 6.9 bn | 5.4 bn | 5.7 bn | SEC (XBRL)· 12 Feb 2026verified |
| Current assets | 14.8 bn | 15.5 bn | 16.8 bn | 16.3 bn | 15.1 bn | 17.3 bn | SEC (XBRL)· 12 Feb 2026verified |
| Property, plant & equipment, net | 4.4 bn | 4.3 bn | 4.3 bn | 4.3 bn | 4.1 bn | 4.2 bn | SEC (XBRL)· 12 Feb 2026verified |
| Goodwill | 10.3 bn | 10.1 bn | 10.0 bn | 10.6 bn | 10.4 bn | 10.5 bn | SEC (XBRL)· 12 Feb 2026verified |
| Intangibles (excl. goodwill) | 10.7 bn | 10.0 bn | 9.3 bn | 9.6 bn | 8.9 bn | 8.3 bn | SEC (XBRL)· 12 Feb 2026verified |
| Total assets | 42.6 bn | 42.3 bn | 42.6 bn | 43.0 bn | 40.8 bn | 42.8 bn | SEC (XBRL)· 12 Feb 2026verified |
| Accounts payable | 3.6 bn | 4.1 bn | 4.9 bn | 4.3 bn | 4.0 bn | 4.4 bn | SEC (XBRL)· 12 Feb 2026verified |
| Short-term debt | 3.0 m | 17.0 m | 24.0 m | 198.0 m | 750.0 m | 894.0 m | SEC (XBRL)· 12 Feb 2026verified |
| Current liabilities | 8.5 bn | 9.6 bn | 10.7 bn | 10.4 bn | 10.4 bn | 12.1 bn | SEC (XBRL)· 12 Feb 2026verified |
| Equity | 25.1 bn | 25.6 bn | 25.5 bn | 25.3 bn | 24.0 bn | 24.4 bn | SEC (XBRL)· 12 Feb 2026verified |
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.1 bn | 2.7 bn | 872.0 m | 1.8 bn | 2.1 bn | 3.4 bn | SEC (XBRL)· 12 Feb 2026verified |
| Capex | 475.0 m | 573.0 m | 605.0 m | 595.0 m | 597.0 m | 591.0 m | SEC (XBRL)· 12 Feb 2026verified |
| Free cash flow | 1.6 bn ≈ | 2.2 bn ≈ | 267.0 m ≈ | 1.2 bn ≈ | 1.5 bn ≈ | 2.8 bn ≈ | SEC (XBRL)· 12 Feb 2026derived |
| Investing cash flow | -674.0 m | -362.0 m | -632.0 m | -2.0 bn | -589.0 m | -543.0 m | SEC (XBRL)· 12 Feb 2026verified |
| Financing cash flow | 303.0 m | -1.3 bn | -1.2 bn | -99.0 m | -1.2 bn | -1.6 bn | SEC (XBRL)· 12 Feb 2026verified |
| Dividends paid | -388.0 m | 397.0 m | 418.0 m | 439.0 m | 458.0 m | 475.0 m | SEC (XBRL)· 12 Feb 2026verified |
| Share repurchases | 275.0 m | 950.0 m | 1.0 bn | 756.0 m | 1.0 bn | 1.1 bn | SEC (XBRL)· 12 Feb 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
Score: 59 / 100
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 8.2 bn USD
Key indicators
Coverage and freshness
Score by group
- Balance sheet60
- Valuation98
- Quality55
- Growth1
- Returns85
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 9.20 – 27.39 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)14.85 – 26.36 (Mid 19.01)WACC 7.9% · starting FCFF 750.3 m USD · terminal value share of EV 77%The WACC × g sensitivity gives the method's bounds; these are not probabilities.Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): -16.2%
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/E22.49 – 27.39 (Mid 25.13)4 companies used · median multiple 16.6x · quartiles 14.9x – 18.1xAGRO, DMC, DOLE, VFF
- Dividend discount (DDM)9.20 – 12.37 (Mid 10.55)
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Neutral profile · Score 59/100
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | 5.7% | 64 (vs peers) | 10% |
| FCF conversion · Quality | 62.3% | 46 (on a fixed band) | 10% |
| Revenue CAGR 3Y · Growth | -0.1% | 0 (on a fixed band) | 13% |
| EPS CAGR 3Y · Growth | 0.4% | 3 (on a fixed band) | 13% |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 1.5x | 60 (on a fixed band) | 7% |
| P/E (TTM) · Valuation | 8.1x | 100 (vs peers) | 17% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 7.7% | 96 (on a fixed band) | 13% |
| Shareholder yield (distributions) · Returns | 18.8% | 100 (on a fixed band) | 10% |
| Payout ratio (FCF) · Returns | 76.9% | 62 (on a fixed band) | 7% |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial60/100 · 1/3 factors with a value
- Growth1/100 · 2/2 factors with a value
- Quality55/100 · 2/3 factors with a value
- Returns85/100 · 2/2 factors with a value
- Valuation98/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Corteva, Inc. (CTVA). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 17.4 bn USD in 2025; YoY growth 2.9%; net margin 5.7%; ROE 4.0%.
The estimated value range is 14.85–26.36 USD per share (median of 3 methods, agreement: low); assumptions are illustrative. Against the central value of 19.01 USD, the price of 12.26 USD leaves a potential of 55.0% (value / price − 1) and a margin of safety of 35.5% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
olivLaw score 59/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: balance. Not investment advice.
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- P/E (TTM): 8.1x
- FCF yield: 7.7%
- Shareholder yield (distributions): 18.8%
- The price is below the estimated value range
What contradicts it
- Revenue CAGR 3Y: -0.1%
- EPS CAGR 3Y: 0.4%
- The valuation methods diverge
Not assessed (insufficient data or a ratio without meaning): ROIC, Net debt / EBITDA, Interest coverage, EV/EBITDA.
Versus the vertical median
Agricultural Production-Crops (SIC 0100) · same industry (4-digit SIC) · compared with 11 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| CTVACorteva, Inc. | 8.2 bn | 8.1 | 4.0% | 5.7% | +2.9% | +31% / +63% |
| DMCDel Monte Corporation | 1.4 bn | 16.8 | 4.0% | 1.9% | +1.0% | −21% / +26% |
| AGROAdecoagro S.A. | 1.3 bn | 10.3 | 7.1% | 6.1% | +16.9% | +14% / −19% |
| DOLEDole plc | 1.3 bn | 21.9 | 4.5% | 0.6% | +8.2% | −4% / +20% |
| VFFVillage Farms International, Inc. | 358.3 m | 16.4 | 7.6% | 9.8% | +10.2% | −26% / +271% |
| LMNRLimoneira Company | 190.7 m | — | -25.7% | -33.0% | −16.6% | −24% / −31% |
| AGRZAgroz Inc. | 42.0 m | 48.0 | 25.6% | 8.6% | unavailable | −98% / unavailable |
| LOCLLocal Bounti Corporation | 22.1 m | — | — | -130.5% | +26.8% | −61% / −73% |
| TULPBloomia Holdings, Inc. | 10.9 m | — | -87.9% | -23.2% | unavailable | −40% / −54% |
| SEEDOrigin Agritech Limited | 8.6 m | — | — | -58.4% | −20.6% | −49% / −64% |
| EDBLEdible Garden AG Incorporated | 1.4 m | — | -197.1% | -51.0% | −7.6% | −100% / −100% |
| LNDBrasilAgro – Brazilian Agricultural Real Estate Company | — | — | 6.3% | 15.7% | +13.8% | −12% / −32% |
1- and 3-year price returns: for CTVA from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 6.90 Total return -39% · Per year -39% | 12.23 Total return 6% · Per year 6% | 18.47 Total return 58% · Per year 58% |
| 3 years | 6.10 Total return -38% · Per year -15% | 12.21 Total return 17% · Per year 5% | 20.32 Total return 88% · Per year 23% |
| 5 years | 5.38 Total return -37% · Per year -9% | 12.18 Total return 29% · Per year 5% | 22.36 Total return 121% · Per year 17% |
- Exit P/E± 3.05
- Net margin± 2.14
- Annual revenue growth± 1.83
- Annual dilution± 0.18
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
Corteva is a global provider of seed and crop protection solutions, headquartered in Indianapolis, aiming to give farmers more productive and sustainable products. The company is nearing a planned separation of its two businesses targeted for October 1, 2026, which keeps its structure and outlook in focus. Net sales reached 17.4 billion USD in 2025, and 11.28 billion USD in the first half of 2026 13.
SWOT
Strengths
- The company has a broad portfolio of seed and crop protection products and a presence in more than a hundred countries 1.
- Its Pioneer agency model, which works directly with farmers, provides real-time insight into future ordering decisions 1.
- Margin expansion in the first half of 2026 shows that cost and productivity measures are having an effect 3.
Weaknesses
Opportunities
Risks
- Regulatory approvalshigh
Products must be tested and approved before sale, and the process can be lengthy, costly and unpredictable, especially for new technologies 1.
- Antitrust investigationshigh
U.S. and foreign authorities could impose fines or restrictions if competition inquiries widen to the company 1.
- Separation into two companiesmedium
The separation process could generate unexpected costs and divert management attention from current operations 13.
- Weather and climate changemedium
Extreme weather can change demand and yields, which could affect sales and inventory levels 1.
- Price pressuremedium
Price competition in Latin America reduced Crop Protection revenue and could keep weighing on margins 3.
Investment thesis
What would need to be true (bull case)
- The company reported higher sales and operating EBITDA in the first half of 2026 and raised full-year guidance, which points to solid execution 3.
- The Seed segment benefits from demand for newer technologies and licensing income, which could support margins over the medium term 3.
- The separation could create two more focused companies with clear strategies, offering greater flexibility if the process closes on schedule 3.
What would break the thesis
- Competitive price pressure in Latin America has reduced Crop Protection sales and could keep weighing on margins if it spreads 3.
- Regulatory risk and antitrust investigations could raise costs or limit growth through acquisitions 1.
- Separation and restructuring carry costs that could reduce near-term results, and sales remain seasonal and weather-sensitive 13.
What to watch
- Completion of the separation and the boards of the two companies2026
- Quarterly results and pricing trends in Latin AmericaQ3 2026
- Delivery against the full-year 2026 operating EBITDA guidance2026
- Progress of the restructuring program and the savings announcednext 10-K
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
Corteva, Inc. is a global provider of seed and crop protection solutions focused on the agriculture industry and a healthier, more secure and sustainable food supply 1. The company was incorporated in Delaware in March 2018, is headquartered in Indianapolis, Indiana, and became an independent public company on June 1, 2019 following its distribution from DowDuPont 1. It operates through two segments, Seed and Crop Protection, and its products reach farmers in approximately 110 countries 1. As of December 31, 2025 it employed approximately 21,500 people globally 1.
On October 1, 2025 the company announced its intent to separate its Seed and Crop Protection businesses into two standalone public companies, in a transaction intended to be a tax-free spin-off for U.S. federal income tax purposes 1. According to 2026 communications, the Crop Protection business will be named Vylor, with the separation targeted for October 1, 2026 3. The company says the goal is two focused companies with greater strategic flexibility 3.
Results are seasonal: sales are strongest in the first half of the calendar year, tied to the northern hemisphere planting season 1. In fiscal 2025 operating EBITDA was 3.85 billion USD, up from the prior year 1. For 2026 the company raised its guidance, which could reflect better product execution and cost control if first-half trends hold 3.
Segments
Seed
The Seed segment develops and supplies commercial seed combining superior germplasm with advanced traits for high yield potential 1. In the first half of 2026 Seed sales were 7.56 billion USD, up 4%, supported by price and mix 3. The segment is a leader in key markets such as North America corn and soybeans 1.
Crop Protection
The Crop Protection segment supplies products that protect crop yields against weeds, insects and disease, along with nitrogen management and biological products 1. In the second quarter of 2026 segment net sales were 1.85 billion USD, with lower prices due to competitive pressure in Latin America, while volume growth from new products supported demand 3. The company's stated focus is operational excellence and disciplined acquisitions 1.
Market context
Corteva operates in the agricultural inputs market: seeds and crop protection products that are strictly regulated and sensitive to weather and government policy 1. Demand depends on season, weather and crop types, and the company describes the industry as highly competitive and consolidating 1. The regulated market and approval framework for new products can change the timing and cost of launches 1.
Recent evidence points to a balanced market with price pressure in some regions; in the second quarter of 2026 net sales fell slightly, by 1%, mainly on lower volume 23. Sales are seasonal and quarterly results can be affected by planting delays 1.
Trends
- Separation into two companiesmixed
Separating Seed and Crop Protection could create two more focused companies with their own capital and strategies, if the process closes on schedule 13. The company says the process remains on track, but separation costs can weigh on near-term results 3.
- Demand for new productstailwind
Demand for newer seed technologies and crop protection products supported volume growth in the first half of 2026 3. If this demand persists, it could support revenue over the medium term 3.
- Price pressure in Latin Americaheadwind
Strong competition in Latin America has lowered crop protection prices, which weighed on segment sales 3. If this pressure persists, margins in the region could stay under strain 3.
- Regulation and agricultural policyheadwind
Government policies and rules on pesticides and biotechnology can change costs and approval timelines 1. A December 2025 executive order calls for antitrust investigations across the food supply chain, which could raise compliance costs 1.
Competitive position
The agricultural inputs industry is highly competitive and has consolidated, which can intensify pressure on prices and products 1. The company operates in markets where competitors invest in similar biotechnology, germplasm and biological products 1. Its advantage rests on speed in developing and launching new products 1.
Competition is most visible in crop protection, where prices fell in Latin America, while in seeds the company maintains its edge through trait technologies and licensing 3. Competitive pressure could affect margins if it spreads to other regions 13.
- Seed and crop protection companies
The sources refer to competitors investing in similar technologies without naming them in the excerpts reviewed.
- Agricultural biotechnology developers
Competition includes companies developing biotechnology traits and germplasm, a category named in the risk discussion 1.
- Biological and chemical product suppliers
The filing notes competitors investing in biological and chemical crop protection products 1.
- Intermediary distribution platforms
A named risk is the emergence of an intermediary platform for distributing the company's products, which could change sales channels 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Acţiunile Corteva, grupul american care deţine la Afumaţi cea mai mare staţie de procesare a seminţelor din România, au scăzut cu 83% după desprinderea afacerii de seminţe VylorZiarul Financiar · 01 Oct 2026 · RO
- Corteva (CTVA) Bets On A Belgian Partner For Crop Protection’s Next ActYahoo Finance — News · 19 Sept 2026 · EN
- Dear Corteva Stock Fans, Mark Your Calendars for September 15Yahoo Finance — News · 15 Sept 2026 · EN
- Corteva Stock: Is CTVA Outperforming the Basic Material Sector?Yahoo Finance — News · 10 Sept 2026 · EN
- Corteva (CTVA) Faces Near-Term Headwinds, but Its Long-Term Growth Story Remains IntactYahoo Finance — News · 28 Aug 2026 · EN
- Corteva evidențiază parteneriatul UE–Ucraina pentru autonomia strategică în comerțul agroalimentarMediafax · 20 May 2026 · RO
The latest news item in our archive is from 01 Oct 2026; the newest SEC filing is from 13 Oct 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.
SEC filings
- Current report13 Oct 2026Other events
- Current report07 Oct 2026Departure or appointment of officers
- Current report07 Oct 2026Item 3.03 · Other events · Financial statements and exhibits
- Current report05 Oct 2026Material agreement · Acquisition or disposition of assets · Financial statements and exhibits
- Current report01 Oct 2026Financial statements and exhibits
- Current report01 Oct 2026Other events
- Current report01 Oct 2026Other events · Financial statements and exhibits
- Current report01 Oct 2026Other events
- Current report30 Sept 2026Other events · Financial statements and exhibits
- Current report25 Sept 2026Other events · Financial statements and exhibits
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Corteva, Inc. · 12 Feb 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Corteva, Inc. · 31 Jul 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Corteva, Inc. · 30 Jul 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.